v3.26.1
RESEARCH AGREEMENTS AND COMMITMENTS (Details)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2026
USD ($)
Feb. 28, 2026
Jun. 30, 2024
USD ($)
Jun. 30, 2024
EUR (€)
Nov. 30, 2020
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jul. 31, 2026
USD ($)
Apr. 30, 2026
AUD ($)
Mar. 31, 2026
USD ($)
Aug. 31, 2024
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
May 31, 2022
USD ($)
Nov. 30, 2021
USD ($)
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Research and development           $ 3,627,168 $ 2,050,585 $ 7,060,930 $ 4,424,724                
Therapeutics Inc.                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Initial term         3 years                        
Written termination notice period         90 days                        
Total amount of agreement                         $ 3,600,000 $ 830,000 $ 4,400,000    
Research and development           303,000 348,000 1,400,000 759,000                
Credit of prior expenses incurred           377,000                      
Therapeutics Inc. | Subsequent Event                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Total amount of agreement                   $ 3,000,000              
Netherton Syndrome                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Total amount of agreement                                 $ 250,000
Research and development           0 0 0 0                
Scleroderma                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Total amount of agreement                               $ 610,000  
Research and development           0 0 0 0                
The School of Pharmacy at UCC                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Research and development           0 $ 60,000 0 $ 120,000                
Maximum funding amount     $ 655,000 € 567,000                          
Commitment period     2 years 6 months 2 years 6 months                          
Evestia Clinical Limited                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Initial term   5 years                              
Written termination notice period   30 days                              
Total amount of agreement                       $ 800,000          
Research and development           280,000   344,000                  
Sapro Consulting Pty Limited                                  
RESEARCH AGREEMENTS AND COMMITMENTS                                  
Written termination notice period 30 days                                
Total amount of agreement $ 1,300,000                   $ 1.8            
Research and development           $ 91,000   $ 91,000